129 related articles for article (PubMed ID: 19348930)
1. A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome.
Kim HJ; Kim JH; Shin YK; Lee SI; Ahn KM
J Allergy Clin Immunol; 2009 Apr; 123(4):956-8. PubMed ID: 19348930
[No Abstract] [Full Text] [Related]
2. A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.
Papanastasiou AD; Mantagos S; Papanastasiou DA; Zarkadis IK
Mol Immunol; 2010 Apr; 47(7-8):1629-34. PubMed ID: 20149460
[TBL] [Abstract][Full Text] [Related]
3. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.
Jiao H; Tóth B; Erdos M; Fransson I; Rákóczi E; Balogh I; Magyarics Z; Dérfalvi B; Csorba G; Szaflarska A; Megarbane A; Akatcherian C; Dbaibo G; Rajnavölgyi E; Hammarström L; Kere J; Lefranc G; Maródi L
Mol Immunol; 2008 Nov; 46(1):202-6. PubMed ID: 18706697
[TBL] [Abstract][Full Text] [Related]
4. [STAT3 mutation identified in patients with Hyper-IgE syndrome].
Picard C
Med Sci (Paris); 2008 Mar; 24(3):242-3. PubMed ID: 18334168
[No Abstract] [Full Text] [Related]
5. [Dominant negative STAT-3 mutations in hyper-IgE syndrome].
Dereure O
Ann Dermatol Venereol; 2008 May; 135(5):432. PubMed ID: 18457738
[No Abstract] [Full Text] [Related]
6. STAT3 signaling and the hyper-IgE syndrome.
Levy DE; Loomis CA
N Engl J Med; 2007 Oct; 357(16):1655-8. PubMed ID: 17881746
[No Abstract] [Full Text] [Related]
7. Hyperimmunoglobulin E syndrome with a novel STAT3 mutation.
Anolik R; Elmariah S; Lehrhoff S; Votava HJ; Martiniuk FT; Levis W
Dermatol Online J; 2009 Aug; 15(8):16. PubMed ID: 19891924
[TBL] [Abstract][Full Text] [Related]
8. Hyper IgE syndrome diagnosed in early infancy by gene analysis of STAT3 mutation.
Watarai A; Niiyama S; Morita M; Bando Y; Minegishi Y; Katsuoka K
Eur J Dermatol; 2011; 21(2):254-5. PubMed ID: 21454152
[No Abstract] [Full Text] [Related]
9. STAT3 mutation in the original patient with Job's syndrome.
Renner ED; Torgerson TR; Rylaarsdam S; Añover-Sombke S; Golob K; LaFlam T; Zhu Q; Ochs HD
N Engl J Med; 2007 Oct; 357(16):1667-8. PubMed ID: 17942886
[No Abstract] [Full Text] [Related]
10. Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome.
Mogensen TH; Jakobsen MA; Larsen CS
Scand J Infect Dis; 2013 Mar; 45(3):235-8. PubMed ID: 22992060
[TBL] [Abstract][Full Text] [Related]
11. Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES).
Spielberger BD; Woellner C; Dueckers G; Sawalle-Belohradsky J; Hagl B; Anslinger K; Bayer B; Siepermann K; Niehues T; Grimbacher B; Belohradsky BH; Renner ED
J Allergy Clin Immunol; 2012 Dec; 130(6):1426-8. PubMed ID: 22981789
[No Abstract] [Full Text] [Related]
12. Hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2009 Oct; 21(5):487-92. PubMed ID: 19717292
[TBL] [Abstract][Full Text] [Related]
13. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.
Minegishi Y; Karasuyama H
Int Immunol; 2009 Feb; 21(2):105-12. PubMed ID: 19088064
[TBL] [Abstract][Full Text] [Related]
14. [Hyper-IgE recurrent infection syndrome: pathogenesis, diagnosis and therapeutic management].
Guisado Vasco P; Fraile Rodríguez G; Arechaga Uriarte S
Rev Clin Esp; 2011 Nov; 211(10):520-6. PubMed ID: 21700278
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.
Schimke LF; Sawalle-Belohradsky J; Roesler J; Wollenberg A; Rack A; Borte M; Rieber N; Cremer R; Maass E; Dopfer R; Reichenbach J; Wahn V; Hoenig M; Jansson AF; Roesen-Wolff A; Schaub B; Seger R; Hill HR; Ochs HD; Torgerson TR; Belohradsky BH; Renner ED
J Allergy Clin Immunol; 2010 Sep; 126(3):611-7.e1. PubMed ID: 20816194
[TBL] [Abstract][Full Text] [Related]
16. Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.
Freeman AF; Domingo DL; Holland SM
Oral Dis; 2009 Jan; 15(1):2-7. PubMed ID: 19036057
[TBL] [Abstract][Full Text] [Related]
17. STAT3 single-nucleotide polymorphisms and STAT3 mutations associated with hyper-IgE syndrome are not responsible for increased serum IgE serum levels in asthma families.
Wjst M; Lichtner P; Meitinger T; Grimbacher B
Eur J Hum Genet; 2009 Mar; 17(3):352-6. PubMed ID: 18841165
[TBL] [Abstract][Full Text] [Related]
18. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome.
Goussetis E; Peristeri I; Kitra V; Traeger-Synodinos J; Theodosaki M; Psarra K; Kanariou M; Tzortzatou-Stathopoulou F; Petrakou E; Fylaktou I; Kanavakis E; Graphakos S
J Allergy Clin Immunol; 2010 Aug; 126(2):392-4. PubMed ID: 20584545
[No Abstract] [Full Text] [Related]
19. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of autosomal-dominant hyperimmunoglobulin E syndrome.
Garcés P; Garcia-Martin F; Detkova D; Espanol T
J Investig Allergol Clin Immunol; 2012; 22(2):149-52. PubMed ID: 22533245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
